Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

Document Type

Article

Publication Date

7-2020

Journal Title

Clinical Rheumatology

MeSH Headings

Betacoronavirus; COVID-19; Coronavirus Infections (complications, physiopathology); Humans; Immunosuppressive Agents (therapeutic use); Pandemics; Pneumonia, Viral (complications, physiopathology); Protective Factors; Rheumatic Diseases (complications, drug therapy); Risk Factors; SARS-CoV-2; Severity of Illness Index

First Page

2067

Last Page

2068

Link to Full Text

Share

COinS